Abiopharma

Hestia Insight Inc. is an AI-driven capital markets advisory and consulting firm focused on helping emerging growth companies raise capital and scale. Using a proprietary AI platform, we support clients through the full fundraising lifecycle—from strategy and asset development to investor outreach and relations. Our services include pre-raise planning, market research, financial modeling, investor materials, and fractional C-suite support. We specialize in healthcare and biotech through our subsidiaries, Hestia Investments Inc. and HSTA Health Inc., while expanding across all sectors. Hestia also pursues strategic acquisitions, licensing, and joint ventures to grow a robust ecosystem of capital markets and business development solutions.

Additional info from OTC:
Hestia Insight Inc. is an AI-driven capital markets advisory and consulting firm focused on helping emerging growth companies raise capital and scale. Using a proprietary AI platform, we support clients through the full fundraising lifecycle—from strategy and asset development to investor outreach and relations. Our services include pre-raise planning, market research, financial modeling, investor materials, and fractional C-suite support. We specialize in healthcare and biotech through our subsidiaries, Hestia Investments Inc. and HSTA Health Inc., while expanding across all sectors. Hestia also pursues strategic acquisitions, licensing, and joint ventures to grow a robust ecosystem of capital markets and business development solutions.

Additional info from NASDAQ:
Insight Enterprises Inc is a Fortune 500 global IT provider primarily engaged in helping businesses of all sizes, large enterprises, governments, schools, and health care organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.